These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 31710084)
1. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Ji YZ; Liu SR Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31710084 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. Hegyi Z; Zwicker S; Bureik D; Peric M; Koglin S; Batycka-Baran A; Prinz JC; Ruzicka T; Schauber J; Wolf R J Invest Dermatol; 2012 May; 132(5):1416-24. PubMed ID: 22402441 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2. Shams K; Kurowska-Stolarska M; Schütte F; Burden AD; McKimmie CS; Graham GJ J Biol Chem; 2018 Feb; 293(8):3003-3012. PubMed ID: 29279330 [TBL] [Abstract][Full Text] [Related]
4. Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis. Batycka-Baran A; Hattinger E; Zwicker S; Summer B; Zack Howard OM; Thomas P; Szepietowski JC; Ruzicka T; Prinz JC; Wolf R J Dermatol Sci; 2015 Sep; 79(3):214-21. PubMed ID: 26055798 [TBL] [Abstract][Full Text] [Related]
5. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Raychaudhuri SP; Jiang WY; Raychaudhuri SK Am J Pathol; 2008 Apr; 172(4):961-71. PubMed ID: 18349121 [TBL] [Abstract][Full Text] [Related]
6. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126 [TBL] [Abstract][Full Text] [Related]
7. Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon. Furue K; Ito T; Tanaka Y; Yumine A; Hashimoto-Hachiya A; Takemura M; Murata M; Yamamura K; Tsuji G; Furue M J Dermatol Sci; 2019 Apr; 94(1):244-251. PubMed ID: 31010609 [TBL] [Abstract][Full Text] [Related]
8. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation. Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571 [TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958 [TBL] [Abstract][Full Text] [Related]
11. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases. Kurpet K; Chwatko G Molecules; 2022 Oct; 27(19):. PubMed ID: 36235175 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and pathogenesis of Koebner phenomenon. Zhang X; Lei L; Jiang L; Fu C; Huang J; Hu Y; Zhu L; Zhang F; Chen J; Zeng Q Exp Dermatol; 2023 Apr; 32(4):310-323. PubMed ID: 36394984 [TBL] [Abstract][Full Text] [Related]
13. Psoriatic keratinocytes are resistant to tumor necrosis factor alpha's induction of mRNA for the NMDA-R2C subunit. Morhenn VB; Nahm WJ; Mansbridge JN Exp Dermatol; 2013 Nov; 22(11):750-1. PubMed ID: 24102971 [TBL] [Abstract][Full Text] [Related]
14. S100A7, Jab1, and p27 Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426 [TBL] [Abstract][Full Text] [Related]
15. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine. Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379 [TBL] [Abstract][Full Text] [Related]
16. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis. Gargalionis AN; Malakou LS; Adamopoulos C; Piperi C; Theohari I; Nokhbehsaim M; Deschner J; Kokkalis G; Korkolopoulou P; Papadavid E; Papavassiliou AG; Basdra EK Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3468-3476. PubMed ID: 30077613 [TBL] [Abstract][Full Text] [Related]
17. Coexistence of Anogenital Psoriasis and Genital Warts - Is There an Optimal Treatment? Ljubojević Hadžavdić S; Budinšćak A; Žužul K; Ljubojević Grgec D; Skerlev M Acta Dermatovenerol Croat; 2019 Dec; 27(4):270-272. PubMed ID: 31969241 [TBL] [Abstract][Full Text] [Related]
18. Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis. Namazi MR Autoimmunity; 2005 Sep; 38(6):449-52. PubMed ID: 16278151 [TBL] [Abstract][Full Text] [Related]
19. Up-regulated lncRNA-MSX2P1 promotes the growth of IL-22-stimulated keratinocytes by inhibiting miR-6731-5p and activating S100A7. Qiao M; Li R; Zhao X; Yan J; Sun Q Exp Cell Res; 2018 Feb; 363(2):243-254. PubMed ID: 29339075 [TBL] [Abstract][Full Text] [Related]